Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Asenapine Maleate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 30,418Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Breckenridge got Final Approval of its ANDA for Asenapine 5 mg Sublingual Tablet
    Breckenridge got Final Approval of its ANDA for Asenapine 5 mg Sublingual Tablet

    08 Mar 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/breckenridge-announces-final-approval-of-its-anda-for-asenapine-sublingual-tablets-5-mg-strength-generic-for-saphris-301242558.html#:~:text=BERLIN%2C%20Conn.%2C%20March%208,(generic%20for%20Saphris%C2%AE).

    PRNEWSWIRE
    08 Mar 2021
    Share Share
    Results from Pivotal, Phase 3 Trial for SECUADO® (asenapine) Published
    Results from Pivotal, Phase 3 Trial for SECUADO® (asenapine) Published

    15 Dec 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20201215006070/en/Results-from-Pivotal-Phase-3-Trial-for-SECUADO%C2%AE-asenapine-Published-in-Journal-of-Clinical-Psychiatry

    BUSINESSWIRE
    15 Dec 2020
    Share Share
    SECUADO® (asenapine) Transdermal System, the First-and-Only Transdermal Patch
    SECUADO® (asenapine) Transdermal System, the First-and-Only Transdermal Patch

    13 Apr 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200413005414/en

    BUSINESSWIRE
    13 Apr 2020
    Share Share
    Alembic Pharma Generic Asenapine Receives Tentative Approval in US
    Alembic Pharma Generic Asenapine Receives Tentative Approval in US

    18 Dec 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206098

    FDA
    18 Dec 2019
    Share Share
    FDA Approves Noven Pharmaceuticals’ Transdermal Patch for Schizophrenia
    FDA Approves Noven Pharmaceuticals’ Transdermal Patch for Schizophrenia

    15 Oct 2019

    // BIOSPACE

    https://www.biospace.com/article/fda-approves-noven-pharmaceuticals-transdermal-patch-for-schizophrenia/?s=95

    BIOSPACE
    15 Oct 2019
    Share Share
    Sigmapharm Labs LLC Generic Asenapine Maleate Receives Tentative Approval In The US
    Sigmapharm Labs LLC Generic Asenapine Maleate Receives Tentative Approval In The US

    11 Oct 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206107

    FDA
    11 Oct 2019
    Share Share